Atlas Trials

Safety and Effectiveness Study of Tocilizumab in Patients With Severe COVID-19

Clinical trial NCT04924829 · UNKNOWN

Trial details

NCT number
NCT04924829
Sponsor
Hospital Italiano de Buenos Aires
Status
UNKNOWN
Study type
OBSERVATIONAL
Severe COVID 19 PneumoniaTocilizumab
Start date
2021-06-01
Primary completion
2021-07-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.